Anorexia Nervosa, Atypical

3

Review clinical trials related to Anorexia Nervosa, Atypical. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Naltrexone Neuroimaging in Teens With Eating Disorders

Using a randomized, placebo-controlled, crossover study, this study will evaluate functional magnetic resonance imaging (fMRI) as a pharmacodynamic biomarker of opioid antagonism in adolescents with eating disorders. The hypothesis is that fMRI will be able to detect acute reward pathway modulation by naltrexone (an opioid antagonist) in pre-defined regions of interest (anterior cingulate cortex, nucleus accumbens, dorsolateral prefrontal cortex).

Participants needed: 60
Trial details
Phase: Early Phase 1Age: 13-21Biological sex: AllType: InterventionalSponsor: Children's Mercy Hospital Kansas CityUpdated: Nov 25, 2025Locations: 1
Eligibility criteria

Adolescents and young adults aged 13-21 years [+3]

Pregnant (via UCG) [+5]

Status: Not yet recruiting

Frequency of Hypermobility-Related Problems in Patients With Anorexia Nervosa

The purpose of this study is to examine the frequense of generalized hypermobility and pain in patients with Anorexia Nervosa. The study further explores two main questions: (1) whether generalized hypermobility may be an explanatory factor for pain in some patients with Anorexia Nervosa, and (2) whether temporomandibular joint problems (such as instability, pain, difficulties opening the mouth, locking, or clicking) contribute to eating difficulties in certain individuals with Anorexia Nervosa.

Participants needed: 100
Trial details
Age: 13-25Biological sex: FemaleType: ObservationalSponsor: Vastra Gotaland RegionUpdated: Sep 8, 2025Locations: 1
Eligibility criteria

Anorexia Nervosa (ICD-10 F50.0), or [+2]

Severe cognitive impairment [+2]

Status: Recruiting

Evaluation of Radically Open Dialectical Behavior Therapy for Youth At Risk for Developing Severe and Enduring Eating Disorders

The goal of this experimental interventional study is to learn if the psychological treatment Radically Open Dialectical Behavior Therapy (RO-DBT), is feasible to conduct and provide positive effects for adolescents with eating disorders and emotional overcontrol. Participants will be those at risk for developing severe and enduring eating disorder symptoms, as they have not responded fully to previous treatment attempts. Primary outcomes are feasibility and changes in eating disorder symptoms. Secondary outcomes are changes in unhelpful behaviors and experiences related to emotional overcontrol; including psychological inflexibility, suppression of emotions, and experience of loneliness. The participants will undergo the treatment with RO-DBT, which include an approximately 22 week long treatment consisting of individual psychotherapy and parallel skills training in group.

Participants needed: 18
Trial details
Age: 14-19Biological sex: AllType: InterventionalSponsor: Uppsala University HospitalUpdated: Jan 24, 2025Locations: 1
Eligibility criteria

Being 14-19 years old [+3]

Eating disorders symptoms in need of emergency care [+2]